Beta-blocking drugs and human platelet aggregation in vitro.
D000433:1-Propanol / Q000494:pharmacology; D000244:Adenosine Diphosphate / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000605:Amino Alcohols / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology; D006801:Humans; D009284:Naphthols / Q000494:pharmacology; D009578:Nitrobenzenes / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D010869:Pindolol / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011433:Propranolol / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D004983:Ethanolamines; D009284:Naphthols; D009578:Nitrobenzenes; D010627:Phenethylamines; D011437:Propylamines; D000244:Adenosine Diphosphate; D000433:1-Propanol; D011433:Propranolol; D010869:Pindolol